Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SAR445877 |
Trade Name | |
Synonyms | SAR 445877|SAR-445877|KD 050|KD-050|KD050|mut-1N-IL-15/38B2 |
Drug Descriptions |
SAR445877 is an antibody cytokine fusion molecule comprising an anti-PD-1 (PDCD1) antibody linked to a mutated fusion of human IL15 and human IL15 receptor-alpha sushi domain, which potentially inhibits tumor growth (Cancer Res (2023) 83 (7_Supplement): 2972). |
DrugClasses | Immune Checkpoint Inhibitor 149 PD-L1/PD-1 antibody 121 |
CAS Registry Number | NA |
NCIT ID | C192821 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
SAR445877 | SAR445877 | 0 | 1 |